| 产品描述: | Product Application:4-Hydroxyquinazoline is been used to inhibit PARP (poly(ADP-ribose) synthetase) which catalyzes covalent attachment of the ADP-ribose moiety of NAD+ to various proteins. This compound specifically and potently inhibits PARP-1. 4-HQN demonstrates the ability to decrease activation of transcription factor NFκB and AP-1 in lipopolysaccharide-induced shock. Mechanistic studies indicate that 4-HQN activates PI3-kinase/Akt pathway in the liver, spleen, and lung and down-regulates two elements of the MAP kinase system. Additionally, this agent has been observed to decrease ischemia-reperfusion-induced increase of protein oxidation, single-strand DNA breaks, lipid peroxidation, and mitochondrial reactive oxygen species production in the reperfusion period. |
| 参考文献: |
1. Mohamed MA, et al. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds. Eur J Med Chem. 2016 Apr 13;112:106-113. 2. Qian Y, et al. Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials[J]. J Med Chem. 2020 May 28;63(10):5287-5296. 3. Gatadi S, et al. 4(3H)-Quinazolinone derivatives: Promising antibacterial drug leads. Eur J Med Chem. 2019 May 15;170:157-172. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
6.842 ml |
34.211 ml |
68.423 ml |
| 5 mM |
1.368 ml |
6.842 ml |
13.685 ml |
| 10 mM |
0.684 ml |
3.421 ml |
6.842 ml |
| 50 mM |
0.137 ml |
0.684 ml |
1.368 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |